Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Stagflation Looms: Why Economists Are Warning of a Rare and Painful Economic Storm April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Lode Gold Completes Final Tranche Financing for Total $1.51 Million August 9, 2025 Prismo Metals Announces Closing of Oversubscribed Private Placement August 9, 2025 Agriculture Market Update: Q2 2025 in Review August 9, 2025